Raymond James analyst Danielle Brill upgraded Acadia Pharmaceuticals to Strong Buy from Outperform. The analyst kept the target at $65.
STA Research has a average target of $55 and a consensus Strong Buy rating.
Acadia Pharmaceuticals(ACAD:NSD) Raymond James Upgrades to Strong Buy
STA Research
November 16th, 2020
Top Trending Stocks
| AVG Analyst Rating | STA Analysis | |
|---|---|---|
Strong Buy
|
Bullish
|
|
Buy
|
Bullish
|
|
Strong Buy
|
Slightly Bearish
|
|
| N/A |
Bearish
|
|
Strong Buy
|
Slightly Bullish
|
|
| N/A |
Slightly Bullish
|
|
|
Strong Buy
|
Bullish
|
|
|
Buy
|
Neutral
|
|
Strong Buy
|
Slightly Bullish
|
|
Hold
|
Slightly Bearish
|
